The Senate Health, Education, Labor and Pensions Committee today voted 18-5 to approve President’s Trump nomination of Stephen Hahn, M.D., to lead the Food and Drug Administration as commissioner. Hahn currently serves as chief medical executive and professor of radiation oncology at The University of Texas MD Anderson Cancer Center in Houston. He previously chaired the Department of Radiation Oncology at the University of Pennsylvania and before that was a senior investigator at the National Cancer Institute.
 
Commenting on the nomination Nov. 1, AHA President and CEO Rick Pollack said Hahn’s “more than 20 years of experience on the front lines of delivering patient care, overseeing clinical research and operations, and quality and safety initiatives makes him a uniquely qualified nominee to lead the FDA.”
 
Scott Gottlieb, M.D., resigned as commissioner this spring. Adm. Brett Giroir, M.D., is currently serving as acting FDA commissioner. Hahn’s nomination will move to the Senate floor for confirmation.

Headline
President Trump announced Aug. 19 that he has nominated Heidi Overton to serve as the next commissioner of the Food and Drug Administration. Overton currently…
Headline
The Senate Aug. 5 voted 51-44 to confirm Erica Schwartz as the new director of the Centers for Disease Control and Prevention. …
Headline
President Trump April 30 announced that Nicole Saphier, M.D., has been nominated to be the next U.S. surgeon general. Saphier is a radiologist and…
Headline
The Senate Health, Education, Labor and Pensions Committee yesterday voted 12-11 along party lines to recommend the confirmation of Brian Christine, M.D., to…
Headline
The Senate April 3 by a vote of 53-45 confirmed Mehmet Oz as the new administrator for the Centers for Medicare & Medicaid Services. 
Headline
The Senate March 25 confirmed Marty Makary as the new commissioner of the Food and Drug Administration and Jay Bhattacharya as the new director of the National…